statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Annovis Bio Raises $7 Million from Warrant Exercises

An update from Annovis Bio (ANVS) is now available. Annovis Bio, Inc. has successfully exercised 0.8 million warrants issued in November 2023, resu...

Maxim Group Sticks to Its Hold Rating for Annovis Bio (ANVS)

Maxim Group analyst Jason McCarthy maintained a Hold rating on Annovis Bio (ANVS Research Report) yesterday. The company's shares opened today at...

Peering Into Annovis Bio's Recent Short Interest

What's Going On With Annovis Shares Today?

Annovis Bio shares rise in premarket trading on positive Phase III Parkinson's study results for buntanetap, showing cognitive improvements and stability compared to placebo.
read more...

Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today

On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory.
read more...

What's Going With Annovis Bio Shares Tuesday?

Annovis announced new data from its Phase III Parkinson's study. The study showed improvements on the Unified Parkinson's Disease Rating Scale following treatment with Buntanetap.
read more...

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors

Law Offices of Howard G. Smith announces an investigation on behalf of Annovis Bio, Inc. (Annovis or the Company) (NYSE: ANVS) investors concerning the Companys possible violations of federal...

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors

Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Annovis Bio, Inc. (Annovis or the Company...

The Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors

The Law Offices of Frank R. Cruz announces an investigation of Annovis Bio, Inc. (Annovis or the Company) (NYSE: ANVS) on behalf of investors concerning the Companys possible violations of federal...

Why Is Alzheimer's-Focused Annovis Bio Stock Nosediving On Monday?

Annovis Bio faces setbacks in Phase 2/3 Alzheimer's study, revealing minimal change in patients' conditions. Despite slight improvements in mild cases, results show no significant difference in...

Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aim to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Malvern, PA.

Volume	371,904.00
52-Wk High	$22.49
52-Wk Low	$4.53

ANVS Annovis Bio Inc

About

Feed

News

Sentiment

Earnings

Fundamentals